Search results
3 major insulin makers have now slashed the price of the life-saving drug. Here's why.
USA TODAY via Yahoo News· 1 year agoAmid consumer angst and political pressure over the cost of life-saving insulin, Sanofi announced...
Sanofi (SNY) to Reduce Lantus Insulin Price by Up to 78%
Zacks via Yahoo Finance· 1 year agoSanofi SNY announced up to a 78% cut in the list price of its most popular insulin, Lantus,...
Tresiba vs. Lantus: Similarities and Differences
Verywell Health via Yahoo News· 4 months agoTresiba (insulin degludec) and Lantus (insulin glargine) are Food and Drug Administration (FDA)-approved synthetic insulins for glycemic control (blood...
Lilly's weekly insulin as effective as daily doses in studies
Reuters via Yahoo News· 13 hours agoLilly and Novo Nordisk are both developing weekly injections for long-acting insulins that could...
Eli Lilly to cut insulin prices up to 70% amid federal pressure to lower costs
USA TODAY via Yahoo News· 1 year agoEli Lilly and Co. said it will cut prices of its most commonly prescribed insulins up to 70% and...
Sanofi announces insulin price cap after actions by Eli Lilly and Novo Nordisk
NBC Universal via AOL· 1 year agoSanofi capped its prices for its popular insulin Lantus following recent actions by Eli Lilly and...
Insulin vs. Blood Sugar: Understanding How to Manage Diabetes
Verywell Health via Yahoo News· 2 years agoInsulin helps lower blood sugar, but with type 2 diabetes, this relationship doesn’t work properly....
Here’s How the Other Major Insulin Makers Are Responding After Eli Lilly’s Price Cap
Time via Yahoo News· 1 year agoBoxes of Eli Lilly & Co. Humalog brand kwikpen insulin delivery devices are arranged for a...
A Verywell Report: Insulin Price Cuts Barely Move the Needle for Americans
Verywell Health via Yahoo News· 1 year agoMonthly price caps and more competition may be more impactful for patients than the slashing of...
What to Do If Your Insulin Is Being Discontinued
Verywell Health via Yahoo News· 3 months agoNovo Nordisk is discontinuing one of its discounted insulin brands, Levemir, because of manufacturing issues, decreasing patient coverage, and the...
